Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers

Purpose: To demonstrate the safety and feasibility of leveraging therapeutic antibodies for surgical imaging. Procedures: We conducted two phase I trials for anti-epidermal growth factor receptor antibodies cetuximab-IRDye800CW (n=12) and panitumumab-IRDye800CW (n=15). Adults with biopsy-confirmed h...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Theranostics
Main Authors: Gao, Rebecca W., Teraphongphom, Nutte, de Boer, Esther, van den Berg, Nynke S., Divi, Vasu, Kaplan, Michael J., Oberhelman, Nicholas J., Hong, Steven S., Capes, Elissa, Colevas, A. Dimitrios, Warram, Jason M., Rosenthal, Eben L.
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2018
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928904/
https://ncbi.nlm.nih.gov/pubmed/29721094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.24487
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki